- Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
- Nymox December 27 Message to Shareholders
- Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others
- $250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court
- Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million
- NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized
- NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023
- IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations
- IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting
- Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting
More ▼
Key statistics
On Friday, Nymox Pharmaceutical Corp (NYMXF:PKC) closed at 0.300, 150.00% above the 52 week low of 0.12 set on Jul 07, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.305 |
---|---|
High | 0.305 |
Low | 0.270 |
Bid | -- |
Offer | -- |
Previous close | 0.300 |
Average volume | 20.97k |
---|---|
Shares outstanding | 93.27m |
Free float | 54.05m |
P/E (TTM) | -- |
Market cap | 27.98m USD |
EPS (TTM) | -0.0536 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 20:33 BST.
More ▼